ACUT
Price
$1.98
Change
+$0.08 (+4.21%)
Updated
Aug 28 closing price
Capitalization
31.82M
BLTE
Price
$65.26
Change
+$0.75 (+1.16%)
Updated
Aug 29, 10:30 AM (EDT)
Capitalization
2.12B
81 days until earnings call
Interact to see
Advertisement

ACUT vs BLTE

Header iconACUT vs BLTE Comparison
Open Charts ACUT vs BLTEBanner chart's image
Accustem Sciences
Price$1.98
Change+$0.08 (+4.21%)
Volume$3.99K
Capitalization31.82M
Belite Bio
Price$65.26
Change+$0.75 (+1.16%)
VolumeN/A
Capitalization2.12B
ACUT vs BLTE Comparison Chart in %
Loading...
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. BLTE commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Buy and BLTE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ACUT: $1.98 vs. BLTE: $64.51)
Brand notoriety: ACUT and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 58% vs. BLTE: 38%
Market capitalization -- ACUT: $31.82M vs. BLTE: $2.12B
ACUT [@Biotechnology] is valued at $31.82M. BLTE’s [@Biotechnology] market capitalization is $2.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, ACUT is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACUT’s TA Score shows that 3 TA indicator(s) are bullish while BLTE’s TA Score has 7 bullish TA indicator(s).

  • ACUT’s TA Score: 3 bullish, 5 bearish.
  • BLTE’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than ACUT.

Price Growth

ACUT (@Biotechnology) experienced а +5.04% price change this week, while BLTE (@Biotechnology) price change was -1.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.15%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.12%.

Reported Earning Dates

BLTE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($2.12B) has a higher market cap than ACUT($31.8M). ACUT YTD gains are higher at: 341.964 vs. BLTE (2.235). ACUT has higher annual earnings (EBITDA): -1.54M vs. BLTE (-50.43M). ACUT (0) and BLTE (0) have equivalent revenues.
ACUTBLTEACUT / BLTE
Capitalization31.8M2.12B2%
EBITDA-1.54M-50.43M3%
Gain YTD341.9642.23515,303%
P/E RatioN/AN/A-
Revenue00-
Total Cash31.3KN/A-
Total Debt66.4KN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACUTBLTE
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
66%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 15 days ago
80%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THYCF25.00N/A
N/A
Taiheiyo Cement Corp.
ELLRY2.40N/A
N/A
Elringklinger Ag
VIIQ0.20N/A
N/A
VisitIQ Corp.
NILIF0.18N/A
-0.03%
Surge Battery Metals Inc.
TLSNY7.35-0.05
-0.68%
Telia Company AB

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and KMSTF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and KMSTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
+4.21%
KMSTF - ACUT
28%
Poorly correlated
N/A
MOLN - ACUT
21%
Poorly correlated
-3.99%
PHGE - ACUT
20%
Poorly correlated
+0.85%
TELIF - ACUT
11%
Poorly correlated
+2.04%
BLTE - ACUT
11%
Poorly correlated
+0.48%
More